1 / 3

Cumulative Incidence Curve for the Risk of Primary Outcome by ß-Blocker Use

Cumulative Incidence Curve for the Risk of Primary Outcome by ß-Blocker Use. Known prior MI matched cohort. HR, 0.90 (95% CI, 0.79-1.03); P = .14. Bangalore S, Steg G, Deedwania P, et al; REACH Registry Investigators . JAMA . 2012;308:1340-9. doi : 10.1001/jama.2012.12559.

andrew
Download Presentation

Cumulative Incidence Curve for the Risk of Primary Outcome by ß-Blocker Use

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cumulative Incidence Curve for the Risk of Primary Outcome by ß-Blocker Use Known prior MI matched cohort HR, 0.90 (95% CI, 0.79-1.03); P = .14 Bangalore S, Steg G, Deedwania P, et al; REACH RegistryInvestigators. JAMA. 2012;308:1340-9. doi: 10.1001/jama.2012.12559.

  2. Cumulative Incidence Curve for the Risk of Primary Outcome by ß-Blocker Use Known CAD without MI matched cohort HR, 0.92 (95% CI, 0.79-1.08); P = .31 Bangalore S, Steg G, Deedwania P, et al; REACH RegistryInvestigators. JAMA. 2012;308:1340-9. doi: 10.1001/jama.2012.12559.

  3. Cumulative Incidence Curve for the Risk of Primary Outcome by ß-Blocker Use Known CAD without MI matched cohort HR, 0.92 (95% CI, 0.79-1.08); P = .31 Bangalore S, Steg G, Deedwania P, et al; REACH RegistryInvestigators. JAMA. 2012;308:1340-9. doi: 10.1001/jama.2012.12559.

More Related